Voyager Therapeutics is a gene therapy company specializing in the development of treatments and next-generation platform technologies. The company is currently working on various preclinical programs for the treatment of Alzheimer's disease, Huntington's disease, and other related conditions. They have also collaborated with several significant companies for research, development and commercialization of adeno-associated virus gene therapy products.